Compagnie Lombard Odier SCmA’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $70K | Hold |
|
|||||
|
2025
Q1 | $70K | Hold |
|
|||||
|
2024
Q4 | $117K | Hold |
|
|||||
|
2024
Q3 | $61.4K | Hold |
|
|||||
|
2024
Q2 | $67.3K | Hold |
|
|||||
|
2024
Q1 | $61.4K | Hold |
|
|||||
|
2023
Q4 | $58.7K | Hold |
|
|||||
|
2023
Q3 | $63.5K | Hold |
|
|||||
|
2023
Q2 | $163K | Hold |
|
|||||
|
2023
Q1 | $236K | Buy |
|
|||||
|
2022
Q4 | $226K | Hold |
|
|||||
|
2022
Q3 | $234K | Hold |
|
|||||
|
2022
Q2 | $214K | Hold |
|
|||||
|
2022
Q1 | $255K | Hold |
|
|||||
|
2021
Q4 | $231K | Buy |
|
|||||
|
2021
Q3 | $354K | Hold |
|
|||||
|
2021
Q2 | $674K | Hold |
|
|||||
|
2021
Q1 | $402K | Buy |
|
|||||
|
2020
Q4 | $519K | Hold |
|
|||||
|
2020
Q3 | $334K | Hold |
|
|||||
|
2020
Q2 | $178K | Hold |
|
|||||
|
2020
Q1 | $202K | Hold |
|
|||||
|
2019
Q4 | $253K | Hold |
|
|||||
|
2019
Q3 | $224K | Buy |
|